FDAnews
www.fdanews.com/articles/75946-amdl-announces-second-closing-of-private-offering

AMDL ANNOUNCES SECOND CLOSING OF PRIVATE OFFERING

August 31, 2005

AMDL, Inc. (Amex: ADL), developer and marketer of tests for the early detection of cancer and other serious diseases, announced today that it has conducted the second closing of a combined Regulation D/Regulation S private offering of shares and warrants. The offering generated total gross proceeds of $1,007,000, exclusive of placement agent fees of $130,910.

Reuters (http://today.reuters.com/stocks/QuoteCompanyNewsArticle.aspx?view=PR&symbol=ADL&storyID=237112%2B30-Aug-2005%2BPRN)